Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Valencak, J. B."'
Autor:
Raderer, M., Kornek, G. V., Hejna, M. H. L., Miholic, J., Weinlaender, G., Brodowicz, T., Fiebiger, W. C. C., Valencak, J. B., Scheithauer, W.
Publikováno v:
European Journal of Cancer; 1998, Vol. 34 Issue: 7 p1128-1130, 3p
Antitumoral and Anti-inflammatory Roles of Somatostatin and Its Analogs in Hepatocellular Carcinoma.
Autor:
Periferakis, Argyrios1 (AUTHOR), Tsigas, Georgios1 (AUTHOR), Periferakis, Aristodemos-Theodoros1 (AUTHOR), Badarau, Ioana Anca1 (AUTHOR), Scheau, Andreea-Elena2 (AUTHOR), Tampa, Mircea3,4 (AUTHOR), Georgescu, Simona Roxana3,4 (AUTHOR), Didilescu, Andreea Cristiana5 (AUTHOR), Scheau, Cristian1 (AUTHOR), Caruntu, Constantin1,6 (AUTHOR)
Publikováno v:
Analytical Cellular Pathology: Cellular Oncology. 11/27/2021, p1-13. 13p.
Publikováno v:
British Journal of Cancer. 11/15/2004, Vol. 91 Issue 10, p1769-1774. 6p.
Autor:
Chakrabarti, Sakti1 (AUTHOR) schakrabarti@mcw.edu, Kamgar, Mandana1 (AUTHOR) mkamgar@mcw.edu, Mahipal, Amit2 (AUTHOR) mahipal.amit@mayo.edu
Publikováno v:
Cancers. Aug2020, Vol. 12 Issue 8, p2039-2039. 1p.
Autor:
Pawlik, Timothy M., Ribero, Dario
Cholangiocarcinoma is a heterogeneous group of neoplasms, which has a rising worldwide incidence. Therefore, it is now a major cause of cancer mortality. Diagnosis, staging, treatment approaches and outcomes differ significantly based on the location
Cholangiocarcinoma is a devastating illness with poor long-term survival. The diagnosis and treatment of cholangocarcinoma is becoming increasingly important, particularly with the increasing incidence of hepatocellular carcinoma, another primary liv